PD Dr. med. habil. Maximilian Pilhatsch

Research focus

Substance use disorders
Affective disorders
Neurobiology (functional neuroimaging & neuroendocrinology)
Development of new technologies and digital applications

Curriculum Vitae

	Pilhatsch, Maximilian, MD, Privatdozent
Official position	Physician-in-Chief, Psychiatric Hospital and Outpatient Clinics, Elblandklinikum Radebeul Head of outpatient Center for Addictive Disorders, Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus
Institution	Elblandklinikum Radebeul, Academic teaching-hospital of the Technische Universität Dresden, Dresden, Germany Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Business address	Fetscherstraße 74, 01307 Dresden

Academic education and degrees

1997-2001	Medicine, Medical School, Rheinische Friedrich-Wilhelms-Universität, Bonn
2001-2005	Medicine, Medical School, Charité Berlin, MD 2005
2011	Dissertation, TU Dresden (thesis advisor: Prof. Dr. Dr. Michael Bauer)
2016	Habilitation, Postdoctoral lecture qualification (venia legendi) in Psychiatry TU Dresden

Professional career

2005-2006	Residency in Psychiatry and Psychotherapy, Charité Berlin, Germany
2007-2013	Residency in Psychiatry and Psychotherapy, TU Dresden, Germany
2011-2013	Postdoctoral researcher, Neuroimaging Center, TU Dresden
2013-2018	Attending physician (Oberarzt), Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden
2018-2020	Head of Clinical Center for Addictive Disorders, Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden
Since 2020	Physician-in-Chief, Psychiatric Hospital and Outpatient Clinics, Elblandklinikum Radebeul (Academic teaching-hospital of the Technische Universität Dresden)
Since 2020	Head of Outpatient Center for Addictive Disorders, Dept. of Psychiatry and Psychotherapy, University Hospital, TU Dresden

Honors, awards and positions

1996	A-levels with top marks (1,0)
2011	Medical doctor thesis work with “summa cum laude”
2013	Selection for “Hot Topics book” of the SfN 2013
2013	Travel Grant (DAAD) SfN / San Diego
2017	Posterpreis „Mitteldeutsche Psychiatrietage“
2017	“MeDDrive” Grant, TU Dresden
Since 2019	Project leader, Collaborative Research Centre TRR 265: Losing and Regaining Control over Drug Intake, DFG
Since 2014	Member International Group for the Study of Lithium-Treated Patients (IGSLI)

Current Journal Editorial positions

Since 2018

Guest Editor, Frontiers in Psychiatry

10 most important peer-reviewed papers

(10 out of 51, Scopus h-index: 18)

Bernhardt N, Petzold J, Groß C, Scheck A, Pooseh S … Pilhatsch M. Neurocognitive Dysfunctions and their Therapeutic Modulation in Patients with Methamphetamine Dependence: A Pilot Study. Front Psychiatry. 2020;11:581.

Petzold J, Weber B, Bassett TR, Bauer M, Bernhardt N … Pilhatsch M. Effectiveness of the First German-Language Group Psychotherapy Manual to Accompany Short-Term Treatment in Methamphetamine Dependence. Front Psychiatry. 2020;11:130.

Kohno M, Beste C, Pilhatsch M. Editorial: The Global Methamphetamine Problem: Approaches to Elucidate the Neurobiology, Epidemiology, and Therapeutic Effectiveness. Front Psychiatry. 2020;11:850.

Pilhatsch M, J Stamm T, Stahl P, Lewitzka U, Berghöfer A et al. Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms. Int J Bipolar Disord. 2019;7(1):21.

Pilhatsch M, Berghöfer A, Mayer-Pelinski R, Berghöfer G, Ricken R et al. Long-term treatment with supraphysiologic doses of levothyroxine in treatment-refractory mood disorders – a prospective study of cardiovascular tolerability. J Affective Disorders. 2018;238:213-217.

Pilhatsch M, Glenn T, Rasgon N, Alda M, Sagduyu K et al. Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder. International Journal of Bipolar Disorders. 2018;6(1):1-9.

Pilhatsch M, Vetter NC, Hübner T, Ripke S, Müller KU et al. Amygdala-function perturbations in healthy mid-adolescents with familial liability for depression. Journal of the American Academy of Child and Adolescent Psychiatry. 2014;53(5):559-68.

Pilhatsch M, Schlagenhauf F, Silverman DH, Berman SM, London ED et al. Antibodies in autoimmune thyroiditis affect glucose metabolism of anterior cingulate. Brain, Behavior & Immunity. 2014;37:73-7.

Pilhatsch M, Wolf R, Schön S, Bauer M. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomised, double-blind study. J Affective Disorders. 2010;126(3):453-7.

Pilhatsch M, Winter C, Nordström K, Vennström B, Bauer M, Juckel G. Increased learned helplessness in mice harboring the mutant thyroid hormone receptor alpha 1. Behavioral Brain research. 2010;214(2):187-92.